A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma

Clinical trial NCT01654692 · COMPLETED

Trial details

NCT number: NCT01654692
Sponsor: Italian Network for Tumor Biotherapy
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Melanoma

Start date: 2010-06-01
Primary completion: 2012-05-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.